It is used for the rescue treatment of upper gastrointestinal vein rupture and bleeding, the treatment of gastric ulcer bleeding, acute pancreatitis, digestive system endocrine tumor, acromegaly, exophthalmic hyperthyroidism, etc.
The main ingredient of this product is octreotide acetate.
Chemical name: D-phenylalanyl-cysteinyl-L-phenylalanyl-D-trypanoyl-L-lysyl-l-threonyl-N -[(1R.2R)-2 hydroxy-1 - (hydroxymethyl) propyl] -L-cysteinamide ring (2→7) -disulfide acetate.
Molecular formula: C49H66N10O10S2·XC2H4O2.
Molecular weight: 1019.26·x60.02.
Excipients: lactic acid, mannitol.
1. Emergency treatment of esophageal and gastric variceal bleeding due to cirrhosis, combined with special treatment (such as endoscopic sclerotherapy).
2. Relieve signs and symptoms associated with gastrointestinal and pancreatic endocrine tumors. There is sufficient evidence that octreotide is effective against the following tumors: carcinoid tumors with carcinoid syndrome; For VIP tumors, octreotide has an effective rate of about 50% for the following tumors.
(1) gastrinoma /Zollinger-Ellison syndrome (usually combined with selective H2 receptor antagonists, with antacids as appropriate).
(2) islet tumor (used to prevent hypoglycemia before islet tumor and maintain normal blood sugar).
(3) Growth hormone releasing factor tumor. Octreotide acetate treatment can only reduce symptoms and signs, but not cure.
3. Prevent postoperative complications of pancreas
4. In patients with acromegaly who have failed to be treated with surgery, radiation therapy or dopamine receptor agonists, symptoms can be controlled and the concentration of growth hormone and auxin mediators C can be reduced. This product is also recommended for patients with acromegaly who are unable or unwilling to undergo surgery, and for patients with intermittent periods when radiation therapy is not effective.
intravenous injection.
1.Patients who are allergic to the ingredients.